10:16 AM EST - Bausch + Lomb Corporation : Announced today that Ophthalmology and Therapy published a new global narrative review examining the causes, burden and management of noninfectious conjunctival hyperemia (ocular redness). The review highlights the growing global prevalence of ocular redness driven by digital lifestyles, dry eye, contact lens wear, allergies and environmental factors, reinforcing how ocular redness affects both comfort and appearance. Bausch + Lomb Corporation
shares T.BLCO are trading up $0.56 at $25.11.
